Sentences with phrase «from global programs»

In this section, you'll find a greater level of control over exactly how your computer handles specific requests from global programs and networked devices like Xboxes, remote desktops, and external email clients.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

The network's 15 live hours a day of business programming in North America (weekdays from 4:00 a.m. - 7:00 p.m. ET) is produced at CNBC's global headquarters in Englewood Cliffs, N.J., and includes reports from CNBC News bureaus worldwide.

Good morning from Paris, where I am moderating a luncheon program today for the city of Guangzhou, host of the 2017 Fortune Global Forum, which will take place in December in that important southern China business center.

A new paper from the Center for Global Development finds that from the early 1990s to 2010, the H - 1B visa program resulted in net gains for the United States and India.

From a relatively sedate program on a quiet campus in north Toronto when he was appointed in 1988, he has built Schulich into one — if global rankings are to believed — that rivals the world's best.

As Mark Cuban suggests, «Knowing how to critically think and assess them from a global perspective, I think, is going to be more valuable than what we see as exciting careers today which might be programming or CPA or those types of things.»

Cardone has provided sales - training programs to large global companies and authored several books on sales strategies, from closing more deals to dominating your market.

Ansi's reported death suggests the covert U.S. drone program against the Yemen branch of the global militant group is continuing, despite the evacuation of American military advisers from the country amid a worsening civil war.

The company recently recruited two Chinese graduates from the University of Washington who joined the beer - maker's global management trainee program.

Enter the DO School, a global institution that, for select programs, borrows students passionate about social change from accredited colleges and offers them experiential learning through doing, challenging them to solve real - world, pressing problems in sustainable ways.

The initial Specializations range from How to Program in Python to Key Trends in Global Affairs.

By now you've probably heard of the U.S. Customs and Border Protection's Trusted Traveler programs: TSA PreCheck ($ 85 for five years), which grants you access to a faster line and allows you to keep your shoes on, and Global Entry ($ 100 for five years), which offers similar perks and speedy entry into the U.S. from abroad.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

21st Century Fox (fox) is the latest global company to weigh in on President Trump's controversial executive order that has banned citizens of seven predominately Muslim nations from visiting the U.S. for 90 days and halted the Syrian refugee program for 120 days.

NextAI is a global innovation program for artificial intelligence - related ventures, and talented teams from around the world are invited to Canada to leverage the nation's leadership in AI and are provided with capital, mentorship, education and networking opportunities.

The iPad will be part of a program created by Kirshenbaum Bond Senecal & Partners, part of the MDC Partners Network, which recently won a global assignment from Puma, which includes building a new web experience and creating an iPad retail solution for the brand's customization platform, Mongolian BBQ.

The network's 15 live hours a day of business programming in North America (weekdays from 4:00 am - 7:00 pm ET) is produced at CNBC's global headquarters in Englewood Cliffs, N.J., and includes reports from CNBC News bureaus worldwide.

Following the program, Startup Next teams that have demonstrated their readiness and progress will also have access to resources from the Startup Next global team, including access to the Techstars network of mentors, entrepreneurs and investors.

Programs of quantitative easing by the Federal Reserve in the United States and by the Bank of England in Britain have helped the economies of those two countries recover from the global financial crisis more successfully than the eurozone has been able to.

The phenomenon is the result of several converging forces: pressure from activist shareholders; executive compensation programs that tie pay to per - share earnings and share prices that buybacks can boost; increased global competition; and fear of making long - term bets on products and services that may not pay off.

These barriers are not unique to Canadian companies, as a recent study by the Asia Pacific Foundation of Canada, «Learning from Global Innovative SME Export Assistance Programs,» demonstrates.

Our entrepreneurs graduating from law, business, computer science or engineering programs need to receive the proper education for commercializing on the global stage.

And although Netflix is facing increasing competition from Hulu and fellow FANG stocks — particularly Amazon and YouTube owner Google — its original programming and massive global expansion have cemented its leadership in the streaming industry.

With the objective of learning from the rich experiences and lessons that other countries have gained from small - and medium - sized enterprise (SME) export assistance programs, the Asia Pacific Foundation of Canada presents a new research report series, «Going Global.»

Upturn in Sentiment Buoys Some Emerging - Market Risk Assets There has been a welcome stabilization in global financial markets in recent weeks, which has been helped by indications from the European Central Bank (ECB) that it stood ready to expand its quantitative easing (QE) program, the possibility that the Bank of Japan (BOJ) might do the same, and a decision by the People's Bank of China (PBOC) to further cut interest rates and relax reserve requirements.

During its first - ever live broadcast of jury deliberations, the Andy Awards revealed the four big winners of its newly revamped awards program: Nike's «Breaking 2» integrated campaign that documented runners attempting to break the two - hour marathon mark, which earned the «Bravery» award; a «Sound of Music» - inspired musical for Orkin, nabbing the Student honor; «Immunity Charm» for the Afghanistan MInistry of Public Health from McCann Worldgroup India, which earned the award for Social Good; and State Street Global Advisors» «Fearless Girl» from McCann New York, which claimed another top honor and earned the best of show Grandy award.

The Global Trade Strategy is designed to help Ontario businesses benefit from the global economy, and provides a framework for the province's role to ensure that programs, policies and international trade agreements reflect the interests of our Province's businesses and woGlobal Trade Strategy is designed to help Ontario businesses benefit from the global economy, and provides a framework for the province's role to ensure that programs, policies and international trade agreements reflect the interests of our Province's businesses and woglobal economy, and provides a framework for the province's role to ensure that programs, policies and international trade agreements reflect the interests of our Province's businesses and workers.

The FITT - accredited program taught me everything from international marketing to global supply chain logistics.

Examples mentioned included the company's programs for spotting and taking down counterfeit - product listings from its online shopping sites, initiatives to simplify the trademark - registration process, reductions in the time it takes to remove counterfeit products, closer partnerships with global law enforcement authorities and governments, and the imposition of a variety of penalties against offending merchants, among others.

Elise Racicot, the CanExport program manager for Global Affairs Canada, emphasizes that companies can reap major benefits from the program and that it can play a big part of an SME's export strategy.

The program recognizes the world's most enterprising technology startups from a global audience.

Other North Bay professionals news from Altus Equity Group, Newmark Knight Frank, Terra Firma Global Partners, In - Shape Health Clubs, Santa Rosa City Schools and Buckelew Programs.

«A growing shortage of highly skilled labour is becoming desperate, threatening our ability to keep up in a global, knowledge - based economy... Our Employment Insurance Program perpetuates regional disparity and discourages Canadians from relocating to where work is available.»

Japan's stock market jumped Monday after global finance leaders gave a seal of approval to the country's stimulus program and refrained from criticizing its weakening effect on the yen.

Well, the last time Americans had a president who was psychologically «programmed» to ignore facts that didn't agree with his beliefs, the USA ended up wasting $ 1T in an illegal war to «liberate» 100's of billions of barrels of Iraqi oil (as many as 1.2 M people died in the process due to violence, disease & starvation resulting from the conflict), nearly $ 5T was added to the U.S. federal debt, a man with experience as the Judges and Stewards Commissioner for the International Arabian Horse Association was put in charge of the Federal Emergency Management Agency (FEMA), the U.S. subprime credit «bubble» expanded hugely & then imploded, wiping out some $ 14T in global wealth & destroying millions of jobs, etc..

Stephan's pursuit of justice led him to transition from a successful career in the Fortune 100 sector to Africa, where he directed relief and development programs for nearly a decade before returning to the United States to lead World Relief's global operations.

Plus, every turkey sold at Whole Foods Market comes from a farm that's achieved certification to Global Animal Partnership's 5 - Step ™ Animal Welfare Rating program.

Our verification program is conducted by third - party technical administrators: FoodChain ID, NSF International, Where Food Comes From (IMI Global), and SCS Global Services.

For example, the company has initiated a program to achieve full SQF certification from the Safe Quality Food Institute (covered under the Global Food Safety Initiative), which includes new protocols for how produce is handled and a complete redesign of the company's warehouse space.

The Rainforest Alliance certification program's steering committee, consisting of senior staff from different departments, ensures effective coordination, information sharing, and planning related to the global sustainable agriculture certification program.

With over 25 years of dedication to the Organic Revolution, Jim, worked from 2008 - 2015 as the Global Certification Program Manager for Oregon Tilth responsible for: monitoring, assessing and interpreting International Organic Standards for clients and staff, and managing international accreditations.

This year's program is set to probe critical global issues from Brexit to climate change, explore the growing sustainability movement, delve into new technology available to the wine trade, and shine the spotlight on small and organic growers.

This year's program is set to probe critical global issues from Brexit to climate change, explore the growing sustainability movement, delve -LSB-...]

«From year to year, this program has honored tremendous achievements,» said Shanna Moore, former DuPont Packaging & Industrial Polymers global director of sustainability and leader of the DuPont Packaging Awards program.»

This has largely been the case for IKEA, though they have made minor adjustments in various programs to improve usability (e.g., limiting the number of «clicks» in the tablet to a minimum, making the icons on the tablet larger, making reports more user - friendly, moving certain data input from store co-workers to the global administration).

As with all Fork in the Road products, the sausages are produced from meat raised without the use of antibiotics and added hormones, and is animal welfare certified under the Global Animal Partnership (GAP) 5 - Step Program.

The grant comes from the Global Environmental Facility, an independent financial organization established in 1990 by the World Bank, the United Nations Environment Program, and the United Nations Development Program.

The CGIAR Research Program for Rice, known as the Global Rice Science Partnership (GRiSP), is a partnership coordinated by six research - for - development organizations that bring together over 900 partners from the academic, public, private, and civil society sectors with a stake in the rice development sector.

SCOTTSDALE, Ariz., May 5, 2016 / PRNewswire / — RiceBran Technologies (NASDAQ: RIBT and RIBTW)(the «Company» or «RBT»), a global leader in the production and marketing of value added products derived from rice bran, announced today that it has entered into two agreements: a Memorandum of Understanding (MOU) with non-profit The Jack Brewer Foundation (JBF Worldwide) to develop rice bran based supplemental feeding programs currently assisted by JBF Worldwide at orphanages in Malawi and Haiti; and a business development agreement with Brewer + Associates Consulting, LLC (B+A) to collaborate on the planned launch of a new line of sports nutrition products with a portion of profits earmarked to provide rice bran based meal supplements for feeding programs covered by the MOU.